Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
| Main Authors: | Jackaman, Connie, Majewski, D., Fox, Simon, nowak, A., Nelson, Delia |
|---|---|
| Format: | Journal Article |
| Published: |
Springer
2012
|
| Online Access: | http://hdl.handle.net/20.500.11937/49084 |
Similar Items
CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy
by: Jackaman, Connie, et al.
Published: (2019)
by: Jackaman, Connie, et al.
Published: (2019)
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
CD40-activated B cells contribute to mesothelioma tumor regression
by: Jackaman, Connie, et al.
Published: (2011)
by: Jackaman, Connie, et al.
Published: (2011)
IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2014)
by: Jackaman, Connie, et al.
Published: (2014)
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ - independent resolution of treated-turmors and CD4+ -dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Murine mesothelioma induces locally-proliferating IL-10+TNF-a+CD206-CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy
by: Jackaman, Connie, et al.
Published: (2016)
by: Jackaman, Connie, et al.
Published: (2016)
Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function
by: Gardner, J., et al.
Published: (2015)
by: Gardner, J., et al.
Published: (2015)
Lipid-laden partially-activated plasmacytoid and CD4-CD8a+ dendritic cells accumulate in tissues in elderly mice
by: Gardner, Joanne, et al.
Published: (2014)
by: Gardner, Joanne, et al.
Published: (2014)
IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
by: Jackaman, Connie, et al.
Published: (2013)
by: Jackaman, Connie, et al.
Published: (2013)
The Reciprocal Interaction: Chemotherapy and Tumor Microenvironment
by: Kim, S., et al.
Published: (2011)
by: Kim, S., et al.
Published: (2011)
Rapid copper acquisition by developing murine mesothelioma: Decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration
by: Crowe, Andrew, et al.
Published: (2013)
by: Crowe, Andrew, et al.
Published: (2013)
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation
by: Gardner, J., et al.
Published: (2018)
by: Gardner, J., et al.
Published: (2018)
Despite generating a weak tumour-specific CTL response during tumour progression chemotherapy is only effective in elderly mice if T cells are present
by: Nelson, D., et al.
Published: (2016)
by: Nelson, D., et al.
Published: (2016)
The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
by: Nelson, Delia, et al.
Published: (2014)
by: Nelson, Delia, et al.
Published: (2014)
Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia
by: Duong, L., et al.
Published: (2018)
by: Duong, L., et al.
Published: (2018)
Turning the tumor microenvironment into a self vaccine site
by: Nelson, Delia
Published: (2012)
by: Nelson, Delia
Published: (2012)
Targeting macrophages rescues age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2016)
by: Jackaman, Connie, et al.
Published: (2016)
Antigen-dependent and antigen-independent pathways modulate CD4 +CD28 null T-cells during atherosclerosis
by: Ammirati, E., et al.
Published: (2012)
by: Ammirati, E., et al.
Published: (2012)
USM BROADENS COLLABORATION WITH INDUSTRY
by: MPRC, Pusat Media & Perhubungan Awam
Published: (2016)
by: MPRC, Pusat Media & Perhubungan Awam
Published: (2016)
The use of agonistic anti-CD40 therapy in treatments for cancer
by: Khong, A., et al.
Published: (2012)
by: Khong, A., et al.
Published: (2012)
The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy
by: Gardner, J., et al.
Published: (2018)
by: Gardner, J., et al.
Published: (2018)
Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules
by: Gardner, J., et al.
Published: (2017)
by: Gardner, J., et al.
Published: (2017)
Human mesothelioma induces defects in dendritic cell numbers and antigen processing function which predict survival outcomes
by: Cornwall, S., et al.
Published: (2015)
by: Cornwall, S., et al.
Published: (2015)
Broadening our understanding of predictors of subjective age
by: Petery, Gigi, et al.
Published: (2017)
by: Petery, Gigi, et al.
Published: (2017)
Does interest broaden or narrow attentional scope?
by: Sung, Billy, et al.
Published: (2015)
by: Sung, Billy, et al.
Published: (2015)
Bromelain enhances the anti-tumor effects of cisplatin on 4T1 breast tumor model in vivo
by: Mohamad, Nurul Elyani, et al.
Published: (2019)
by: Mohamad, Nurul Elyani, et al.
Published: (2019)
Sarcostemma viminale activates macrophages to a pro-inflammatory phenotype
by: Brestovac, Brian, et al.
Published: (2014)
by: Brestovac, Brian, et al.
Published: (2014)
TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
by: Zhang, Guanglan, et al.
Published: (2021)
by: Zhang, Guanglan, et al.
Published: (2021)
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix
by: Rahman, Cheryl V., et al.
Published: (2013)
by: Rahman, Cheryl V., et al.
Published: (2013)
Consuming Alone: Broadening Putnam's "Bowling Alone" Thesis
by: Rauch, A., et al.
Published: (2015)
by: Rauch, A., et al.
Published: (2015)
University Knowledge Management: proposal for broaden integrative perspective
by: Ayodele, Freida Ozavize, et al.
Published: (2018)
by: Ayodele, Freida Ozavize, et al.
Published: (2018)
In-Vivo Induced Antigens
Of Toxoplasma Gondii And Their Application
In Diagnosis Of Human Toxoplasmosis
by: Amerizadeh, Atefeh
Published: (2015)
by: Amerizadeh, Atefeh
Published: (2015)
In vivo anti-tumor effects of Azadirachta indica in rat liver cancer.
by: Mohamed Elhassan Taha , Manal, et al.
Published: (2009)
by: Mohamed Elhassan Taha , Manal, et al.
Published: (2009)
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
by: Ismail, Ruzila, et al.
Published: (2016)
by: Ismail, Ruzila, et al.
Published: (2016)
In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system
by: Bwatanglang, Ibrahim Birma, et al.
Published: (2016)
by: Bwatanglang, Ibrahim Birma, et al.
Published: (2016)
Combining chemotherapy with immunotherapy to treat mesothelioma: an investigation into the role of CD4+ T cells in a murine model
by: Steer, Henry John
Published: (2013)
by: Steer, Henry John
Published: (2013)
Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice
by: Jackaman, Connie, et al.
Published: (2013)
by: Jackaman, Connie, et al.
Published: (2013)
Cortical imaging as seen at ultrahigh field MRI
by: Abdel-Fahim, Rasha
Published: (2017)
by: Abdel-Fahim, Rasha
Published: (2017)
Evolutionary phases of merging clusters as seen by LOFAR
by: Wilber, A., et al.
Published: (2019)
by: Wilber, A., et al.
Published: (2019)
Similar Items
-
CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy
by: Jackaman, Connie, et al.
Published: (2019) -
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012) -
CD40-activated B cells contribute to mesothelioma tumor regression
by: Jackaman, Connie, et al.
Published: (2011) -
IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2014) -
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ - independent resolution of treated-turmors and CD4+ -dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)